Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma
Open Access
- 17 June 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (33) , 53911-53920
Abstract
Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinomaKeywords
This publication has 40 references indexed in Scilit:
- Safety and Efficacy of Radiofrequency Ablation in the Management of Unresectable Bile Duct and Pancreatic Cancer: A Novel Palliation TechniqueJournal of Oncology, 2013
- Pathological aspects of so called "hilar cholangiocarcinoma"World Journal of Gastrointestinal Oncology, 2013
- Percutaneous Intraductal Radiofrequency Ablation is a Safe Treatment for Malignant Biliary Obstruction: Feasibility and Early ResultsCardioVascular and Interventional Radiology, 2012
- Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancerAlimentary Pharmacology & Therapeutics, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Surgical strategy for bile duct cancer: Advances and current limitationsWorld Journal of Clinical Oncology, 2011
- Preoperative Biliary Drainage for Cancer of the Head of the PancreasNew England Journal of Medicine, 2010
- CholangiocarcinomaAnnals of Surgery, 2007
- Changing Strategies in Diagnosis and Management of Hilar CholangiocarcinomaLiver Transplantation, 2000
- Changing strategies in diagnosis and management of hilar cholangiocarcinomaLiver Transplantation, 2000